Abstract

Abstract A strengthened local supply chain is an essential and highly relevant condition for universal access to health care. This article enables a movement towards a public policy agenda that involve the entire productive health system, including strategic components of the production chain beyond active pharmaceutical ingredients (API), without which universal health access and health sovereignty become unfeasible, leaving the Brazilian Unified Health System (SUS) vulnerable. Within this perspective, qualitative bibliographic research was conducted together with field observation among key informants of the drug production supply chain from Brazil’s main Official Pharmaceutical Laboratory. Results showed that in addition to active pharmaceutical ingredients, other strategic health care items in the supply chain also constitute technological bottlenecks. These findings may contribute to expand the debate on health vulnerabilities, relating the productive and economic structure to universal access, thus establishing, nationally and internationally, a theoretical link between the economy, production local and social rights.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.